- Home
- ABOS vs MRCC Comparison
ABOS vs MRCC Comparison
Compare ABOS & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- MRCC
- Stock Information
- Founded
- ABOS 1996
- MRCC 2011
- Country
- ABOS United States
- MRCC United States
- Employees
- ABOS N/A
- MRCC N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- MRCC Investment Managers
- Sector
- ABOS Health Care
- MRCC Finance
- Exchange
- ABOS Nasdaq
- MRCC Nasdaq
- Market Cap
- ABOS 84.2M
- MRCC 155.1M
- IPO Year
- ABOS 2021
- MRCC 2012
- Fundamental
- Price
- ABOS $1.32
- MRCC $7.63
- Analyst Decision
- ABOS Strong Buy
- MRCC Hold
- Analyst Count
- ABOS 3
- MRCC 1
- Target Price
- ABOS $8.00
- MRCC $8.00
- AVG Volume (30 Days)
- ABOS 183.8K
- MRCC 72.3K
- Earning Date
- ABOS 11-11-2025
- MRCC 11-11-2025
- Dividend Yield
- ABOS N/A
- MRCC 13.07%
- EPS Growth
- ABOS N/A
- MRCC N/A
- EPS
- ABOS N/A
- MRCC 0.09
- Revenue
- ABOS N/A
- MRCC $51,229,000.00
- Revenue This Year
- ABOS N/A
- MRCC N/A
- Revenue Next Year
- ABOS N/A
- MRCC N/A
- P/E Ratio
- ABOS N/A
- MRCC $86.60
- Revenue Growth
- ABOS N/A
- MRCC N/A
- 52 Week Low
- ABOS $0.86
- MRCC $5.96
- 52 Week High
- ABOS $3.36
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- ABOS 47.15
- MRCC 74.61
- Support Level
- ABOS $1.21
- MRCC $7.41
- Resistance Level
- ABOS $1.47
- MRCC $7.65
- Average True Range (ATR)
- ABOS 0.08
- MRCC 0.13
- MACD
- ABOS -0.01
- MRCC -0.03
- Stochastic Oscillator
- ABOS 42.31
- MRCC 77.42
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.